Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis

NCT04222114 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: Catumaxomab
DRUG: The treatment of investigator choice

Sponsor

LintonPharm Co.,Ltd.